| Primary |
| Menopause |
35.5% |
| Hormone Replacement Therapy |
17.8% |
| Depression |
13.0% |
| Menopausal Symptoms |
6.9% |
| Hypertension |
3.6% |
| Pain |
3.0% |
| Anxiety |
2.6% |
| Hypersensitivity |
2.4% |
| Blood Cholesterol Increased |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Diuretic Therapy |
1.6% |
| Hot Flush |
1.6% |
| Blood Cholesterol |
1.4% |
| Sleep Disorder |
1.4% |
| Angina Pectoris |
1.3% |
| Arthritis |
1.0% |
| Hypothyroidism |
1.0% |
| Hormone Therapy |
0.9% |
| Vulvovaginal Dryness |
0.9% |
| Blood Iron Increased |
0.7% |
|
| Vaginal Haemorrhage |
7.1% |
| Weight Decreased |
7.1% |
| Wrist Surgery |
7.1% |
| Ventricular Extrasystoles |
6.3% |
| Vulvovaginal Dryness |
6.3% |
| Wound |
6.3% |
| Metrorrhagia |
5.4% |
| Uterine Haemorrhage |
5.4% |
| Product Quality Issue |
4.5% |
| Pruritus |
4.5% |
| Radiotherapy |
4.5% |
| Tooth Extraction |
4.5% |
| Vomiting |
4.5% |
| Vulvovaginal Candidiasis |
4.5% |
| Withdrawal Syndrome |
4.5% |
| Osteopenia |
3.6% |
| Product Adhesion Issue |
3.6% |
| Skin Irritation |
3.6% |
| Surgery |
3.6% |
| Uterine Leiomyoma |
3.6% |
|
| Secondary |
| Hormone Replacement Therapy |
46.8% |
| Menopause |
17.1% |
| Menopausal Symptoms |
8.7% |
| Depression |
6.8% |
| Hot Flush |
3.1% |
| Pain |
2.7% |
| Anxiety |
2.5% |
| Hypercholesterolaemia |
1.6% |
| Nausea |
1.3% |
| Cardiac Disorder |
1.1% |
| Insomnia |
1.1% |
| Herpes Virus Infection |
1.0% |
| Meniere's Disease |
1.0% |
| Blood Pressure Management |
0.9% |
| Cerebrovascular Accident Prophylaxis |
0.9% |
| Ill-defined Disorder |
0.7% |
| Oestrogen Replacement Therapy |
0.7% |
| Sleep Disorder |
0.7% |
| Hypersensitivity |
0.5% |
| Hypertension |
0.4% |
|
| Breast Cancer |
45.6% |
| Breast Cancer Female |
21.3% |
| Breast Cancer Metastatic |
4.6% |
| Pain |
4.2% |
| Uterine Leiomyoma |
2.7% |
| Contralateral Breast Cancer |
2.3% |
| Weight Decreased |
2.3% |
| Menstruation Irregular |
1.9% |
| Pruritus |
1.9% |
| Vulvovaginal Candidiasis |
1.9% |
| Breast Cancer In Situ |
1.5% |
| Osteopenia |
1.5% |
| Vision Blurred |
1.5% |
| Uterine Polyp |
1.1% |
| Vomiting |
1.1% |
| Vulvar Dysplasia |
1.1% |
| Vulvovaginal Discomfort |
1.1% |
| Epilepsy |
0.8% |
| Fatigue |
0.8% |
| Hot Flush |
0.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.4% |
| Osteopenia |
7.5% |
| Hormone Replacement Therapy |
5.9% |
| Breast Cancer Metastatic |
5.5% |
| Drug Use For Unknown Indication |
5.5% |
| Hot Flush |
5.2% |
| Osteoporosis |
5.2% |
| Blood Cholesterol Increased |
4.2% |
| Rheumatoid Arthritis |
3.6% |
| Depression |
3.3% |
| Breast Cancer |
2.9% |
| Constipation |
2.9% |
| Metastases To Bone |
2.9% |
| Muscle Spasms |
2.9% |
| Smoking Cessation Therapy |
2.9% |
| Bipolar Disorder |
2.6% |
| Hypertension |
2.6% |
| Migraine |
2.3% |
| Pain |
2.3% |
| Prophylaxis |
2.3% |
|
| Sinusitis |
11.1% |
| Weight Increased |
9.3% |
| Weight Decreased |
7.4% |
| Heart Rate Increased |
5.6% |
| Pain |
5.6% |
| Urinary Tract Infection |
5.6% |
| Vomiting |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| Breast Cancer |
3.7% |
| Depression |
3.7% |
| Dyspnoea |
3.7% |
| Hepatic Enzyme Abnormal |
3.7% |
| Insomnia |
3.7% |
| Muscle Strain |
3.7% |
| Muscular Weakness |
3.7% |
| Optic Nerve Disorder |
3.7% |
| Red Blood Cell Count Decreased |
3.7% |
| Suicidal Ideation |
3.7% |
| Syncope |
3.7% |
| Urine Output Decreased |
3.7% |
|
| Interacting |
|
|
